BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28390436)

  • 1. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma.
    Valiulyte I; Steponaitis G; Skiriute D; Tamasauskas A; Vaitkiene P
    BMC Med Genet; 2017 Jul; 18(1):72. PubMed ID: 28709401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
    Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
    Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
    Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
    Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
    PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles.
    Cheng S; Xie W; Miao Y; Guo J; Wang J; Li C; Zhang Y
    J Transl Med; 2019 Dec; 17(1):407. PubMed ID: 31796052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
    Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
    J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
    Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
    Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.
    Yaron M; Renner U; Gilad S; Stalla GK; Stern N; Greenman Y
    Pituitary; 2015 Jun; 18(3):306-11. PubMed ID: 24817066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
    Shao S; Li X
    J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.
    Wu Y; Bai J; Li Z; Wang F; Cao L; Liu C; Yu S; Yu G; Zhang Y
    Pituitary; 2015 Jun; 18(3):335-42. PubMed ID: 24917361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
    Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.
    Ling C; Pease M; Shi L; Punj V; Shiroishi MS; Commins D; Weisenberger DJ; Wang K; Zada G
    PLoS One; 2014; 9(4):e96178. PubMed ID: 24781529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
    Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
    Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.